Treatments for multiple myeloma, unfortunately, can cause side effects, such as toxicities from chemotherapy, fatigue, and increased susceptibility to infections. Managing these side effects, as well as any other medical conditions, helps patients to feel as well as possible and to adhere to their treatment plan with minimal interruption.
To address this important aspect of patient care, the Myeloma Institute for Research and Therapy has assembled a Supportive Care Team charged with preventing and managing any complications that may arise during treatment. The team includes advanced practice nurses to help patients in the outpatient setting and hospitalists to care for patients admitted to the hospital.
Most patients at the Myeloma Institute receive their care on an outpatient basis. Our advanced practice nurses, all of whom are specially trained in myeloma and related diseases, closely monitor and manage patient treatment and care throughout the various outpatient treatment areas.
Hospitalists at the Myeloma Institute have completed residencies in internal medicine, and some also have fellowship training in infectious diseases. They undergo in-depth training at the University of Arkansas for Medical Sciences to become experts in all aspects of inpatient care for patients with myeloma and related diseases. Constant communication between hospitalists and clinic physicians ensures that treatment goals are optimized for each patient during any hospitalizations.